ReviewResearch and practice in thrombosis and haemostasis2023
Implementing guidelines to prevent cancer associated thrombosis: how can we do better?
Review in Research and practice in thrombosis and haemostasis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Platelet FcɣRIIa: a novel biomarker of risk for thromboembolism and death in cancer.Journal of thrombosis and thrombolysis · 2026Observational
- Adherence of Oncologists and Cardiologists to Venous Thromboembolic Disease Prevention and Treatment Guidelines in Cancer Patients: A Cross-Sectional Survey from Turkey.Journal of clinical medicine · 2026Article
- The public health impact of cancer-associated venous thromboembolism: looking to the future.Research and practice in thrombosis and haemostasis · 2026Article
- Implementation failure: thromboprophylaxis in ambulatory patients with cancer.Hematology. American Society of Hematology. Education Program · 2025Review
- Time to move beyond risk assessment models for ambulatory cancer-associated thrombosis.Research and practice in thrombosis and haemostasis · 2025Article
- Observational
- Venous thromboembolism prevention program implementation in a community oncology practice: a cohort study.Lancet regional health. Americas · 2024Article
- Preventing venous thromboembolism for ambulatory patients with cancer: Developing the form and content of implementation strategies.Thrombosis update · 2024Article
- Implementation of a cancer-associated thrombosis prevention program at a rural cancer center.Research and practice in thrombosis and haemostasis · 2024Article
- Venous thromboembolism prevention in cancer care: implementation strategies to address underuse.Research and practice in thrombosis and haemostasis · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.